Electronic Patient Reported Outcomes in Patients with Gastrointestinal Cancers at Risk for Unplanned Emergency Department Visits and Hospitalizations

PRIMARY OBJECTIVES:

I. To evaluate the feasibility of the ePRO platform by describing the proportion of patients who engages with the ePRO tool via virtual care chat at least once after enrollment.

II. To investigate the potential differences in health-related quality of life (HRQoL) over the study period of 6 months between the patients in the intervention and usual care arms.

SECONDARY OBJECTIVES:

I. To evaluate the degree of engagement with virtual care chat.

II. To measure the potential differences in health-related quality of life (HRQoL) via European Quality of Life Five Dimension Five Level Scale Questionnaire (EQ-5D) from enrollment to the completion of the study in the intervention and usual care arm.

III. To describe the symptom experience of patients on the intervention arm.

IV. To evaluate the performance of clinical escalation rules and impact on clinic workflow and efficiency for the clinical team.

V. To prospectively validate a risk model predicting emergency department (ED) visits and admissions due to treatment side effects.

EXPLORATORY OBJECTIVES:

I. To compare unplanned ED visits and hospitalizations between intervention arm and control arm.

II. To compare referral patterns to Symptom Management Clinic during the study period.

III. To compare concordance between patient self-reported and provider assigned Eastern Cooperative Oncology Group (ECOG) performance status.

OUTLINE: Patients are randomized to 1 of 2 groups.

GROUP A: Patients report their symptoms for 6 months via standard of care messaging through MyChart or telephone calls.

GROUP B: Patients report their symptoms for 6 months via ePRO platform on days 4 and 7 after infusion of cycle 1, weekly, and 2 days before every scheduled visit with provider team.